CB

Chandrakan Bandi

Active Director Director DIN 09420342
DIN 09420342 First appointment Dec 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Chandrakan Bandi

Data last updated:

Chandrakan Bandi is a Director at Aira Medicos Private Limited (since 2021). The company operates in Healthcare. Aira Medicos Private Limited reported revenue of ₹5.04 Cr (FY 2025).

DIN 09420342
Primary Designation Director
Industry Healthcare
First Appointment 01 Dec 2021
Oldest Company Age 4 yrs
Largest company Aira Medicos Private Limited · ₹5.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aira Medicos Private Limited U85300TG2021PTC157522
Director01 Dec 20212021₹5.04 Cr (FY 2025)Active

Board colleagues of Chandrakan Bandi

Directorship timeline

Open interactive timeline →
Aira Medicos Private Limited
Premium access

Shareholding and investment profile for Chandrakan Bandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrakan Bandi

Chandrakan Bandi currently holds 1 directorship: Aira Medicos Private Limited (Director, since 01 Dec 2021, revenue ₹5.04 Cr (FY 2025)).

Chandrakan Bandi was first appointed on 01 Dec 2021 as Director at Aira Medicos Private Limited.

The current boards of Chandrakan Bandi's companies include Harish Laxman Borra (Aira Medicos Private Limited), Sandeep Reddy Chitukula (Aira Medicos Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available